Biology of Bladder Cancer From Molecular Insights to Clinical Strategies
Produktdetaljer
Biographical note
Maggie Knowles, PhD is Emeritus Professor of Experimental Cancer Research at the University of Leeds in the UK. She has worked on bladder cancer for more than forty years with the goal of improving disease management through molecular studies. Her work has included identification of key genes involved in the development of bladder cancer, sub-classification of non-invasive tumours through genomic and transcriptional analyses and development of in vitro models for preclinical validation of potential therapeutic targets and improved understanding of gene function. Her extensive publications and leadership roles have played an important part in shaping bladder cancer research over the past two decades.
Lars Dyrskjøt, PhD, is a Professor of Molecular Medicine at Aarhus University in Denmark, where he leads a team focused on translational bladder cancer research. His work has greatly enhanced understanding of the disease’s molecular pathogenesis, especially through the identification of prognostic and predictive biomarkers in early-stage bladder cancer, and the innovative use of liquid biopsies for monitoring and guiding treatment in advanced bladder cancer. With his extensive publications and leadership roles in international cancer research initiatives, Prof. Dyrskjøt plays a crucial role in advancing the global discourse on bladder cancer.
Produktdetaljer
Biographical note
Maggie Knowles, PhD is Emeritus Professor of Experimental Cancer Research at the University of Leeds in the UK. She has worked on bladder cancer for more than forty years with the goal of improving disease management through molecular studies. Her work has included identification of key genes involved in the development of bladder cancer, sub-classification of non-invasive tumours through genomic and transcriptional analyses and development of in vitro models for preclinical validation of potential therapeutic targets and improved understanding of gene function. Her extensive publications and leadership roles have played an important part in shaping bladder cancer research over the past two decades.
Lars Dyrskjøt, PhD, is a Professor of Molecular Medicine at Aarhus University in Denmark, where he leads a team focused on translational bladder cancer research. His work has greatly enhanced understanding of the disease’s molecular pathogenesis, especially through the identification of prognostic and predictive biomarkers in early-stage bladder cancer, and the innovative use of liquid biopsies for monitoring and guiding treatment in advanced bladder cancer. With his extensive publications and leadership roles in international cancer research initiatives, Prof. Dyrskjøt plays a crucial role in advancing the global discourse on bladder cancer.